← Leaderboards
Sung Wan Kim
University Of Utah
$13,234,593
Attributed
$13,234,593
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$13,234,593 · 7
By mechanism
R01$13,234,593 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- David Andrew Bull$3,607,454
- Scott C. Miller$2,415,010
Others in their field
Top investigators on “Polymers”
- Marc A Hillmyer · University Of Minnesota-Twin Cities$45,350,238
- Michael F Rubner · Massachusetts Institute Of Technology$44,168,921
- Nicholas Hud · Emory University$41,051,104
- Timothy P Lodge · Gordon Research Conferences$40,942,324
- Eric Baer · Case Western Reserve University$37,476,250
- Robert S Langer · Massachusetts Institute Of Technology$29,222,504
Research focus
PolymersGene TherapyAnimal ModelIn VitroCellsPlasmidsTransfectionDesignViralGenesMediatingCystamineZeta PotentialResearch StudyIn VivoCharacteristicsSafetyToxic EffectComplexGene TransferGene DeliveryRattusTumorVector
Grant awards (45)
Design of Oncolytic Adenovirus Conjugated with Novel Polymer for Cancer Treatment$309,175
R01 · FY2017 · CA · contact PI
Design of Oncolytic Adenovirus Conjugated with Novel Polymer for Cancer Treatment$309,175
R01 · FY2016 · CA · contact PI
Design of Oncolytic Adenovirus Conjugated with Novel Polymer for Cancer Treatment$309,175
R01 · FY2015 · CA · contact PI
Design of Oncolytic Adenovirus Conjugated with Novel Polymer for Cancer Treatment$299,900
R01 · FY2014 · CA · contact PI
MODIFIED POLY(DISULFIDE AMINE)AS A PANCREAS TARGETING POLYMERIC VECTOR$266,846
R01 · FY2014 · DK · contact PI
Design of Oncolytic Adenovirus Conjugated with Novel Polymer for Cancer Treatment$309,175
R01 · FY2013 · CA · contact PI
MODIFIED POLY(DISULFIDE AMINE)AS A PANCREAS TARGETING POLYMERIC VECTOR$257,794
R01 · FY2013 · DK · contact PI
RGD-POLYMER TARGETING PLASMID TO ANGIOGENIC ENDOTHELIUM$247,262
R01 · FY2013 · CA · contact PI
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$335,239
R01 · FY2012 · HL · contact PI
MODIFIED POLY(DISULFIDE AMINE)AS A PANCREAS TARGETING POLYMERIC VECTOR$267,741
R01 · FY2012 · DK · contact PI
RGD-POLYMER TARGETING PLASMID TO ANGIOGENIC ENDOTHELIUM$263,045
R01 · FY2012 · CA · contact PI
REDUCIBLE POLYAMIDO ETHYLENIMINE FOR GLP-1 PLASMID DELIVERY$258,135
R01 · FY2012 · DK · contact PI
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$338,625
R01 · FY2011 · HL · contact PI
MODIFIED POLY(DISULFIDE AMINE)AS A PANCREAS TARGETING POLYMERIC VECTOR$268,338
R01 · FY2011 · DK · contact PI
RGD-POLYMER TARGETING PLASMID TO ANGIOGENIC ENDOTHELIUM$263,045
R01 · FY2011 · CA · contact PI
REDUCIBLE POLYAMIDO ETHYLENIMINE FOR GLP-1 PLASMID DELIVERY$258,135
R01 · FY2011 · DK · contact PI
MODIFIED POLY(DISULFIDE AMINE)AS A PANCREAS TARGETING POLYMERIC VECTOR$338,625
R01 · FY2010 · DK · contact PI
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$338,625
R01 · FY2010 · HL · contact PI
RGD-POLYMER TARGETING PLASMID TO ANGIOGENIC ENDOTHELIUM$271,181
R01 · FY2010 · CA · contact PI
REDUCIBLE POLYAMIDO ETHYLENIMINE FOR GLP-1 PLASMID DELIVERY$260,741
R01 · FY2010 · DK · contact PI
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$338,625
R01 · FY2009 · HL · contact PI
RGD-POLYMER TARGETING PLASMID TO ANGIOGENIC ENDOTHELIUM$271,181
R01 · FY2009 · CA · contact PI
REDUCIBLE POLYAMIDO ETHYLENIMINE FOR GLP-1 PLASMID DELIVERY$263,375
R01 · FY2009 · DK · contact PI
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$318,945
R01 · FY2008 · HL · contact PI
FUNCTIONAL BIOMATERIALS FOR ANTISENSE DELIVERY TO ISLET$293,812
R01 · FY2008 · DK · contact PI
REDUCIBLE POLYAMIDO ETHYLENIMINE FOR GLP-1 PLASMID DELIVERY$262,501
R01 · FY2008 · DK · contact PI
RGD-Polymer Targeting Plasmid to Angiogenic Endothelium$261,534
R01 · FY2008 · CA · contact PI
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$318,945
R01 · FY2007 · HL · contact PI
FUNCTIONAL BIOMATERIALS FOR ANTISENSE DELIVERY TO ISLET$299,809
R01 · FY2007 · DK · contact PI
RGD-Polymer Targeting Plasmid to Angiogenic Endothelium$261,534
R01 · FY2007 · CA · contact PI
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$328,471
R01 · FY2006 · HL · contact PI
FUNCTIONAL BIOMATERIALS FOR ANTISENSE DELIVERY TO ISLET$308,762
R01 · FY2006 · DK · contact PI
RGD-Polymer Targeting Plasmid to Angiogenic Endothelium$269,345
R01 · FY2006 · CA · contact PI
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$336,375
R01 · FY2005 · HL
FUNCTIONAL BIOMATERIALS FOR ANTISENSE DELIVERY TO ISLET$316,193
R01 · FY2005 · DK
RGD-Polymer Targeting Plasmid to Angiogenic Endothelium$275,828
R01 · FY2005 · CA
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$337,500
R01 · FY2004 · HL
FUNCTIONAL BIOMATERIALS FOR ANTISENSE DELIVERY TO ISLET$316,193
R01 · FY2004 · DK
RGD-Polymer Targeting Plasmid to Angiogenic Endothelium$275,828
R01 · FY2004 · CA
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$337,500
R01 · FY2003 · HL
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$337,500
R01 · FY2002 · HL
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$337,500
R01 · FY2001 · HL
ANTIGAD MAB POLYMER CONJUGATES FOR DIABETES TREATMENT$233,809
R01 · FY2001 · DK
FUNCTIONAL AND TARGETING POLYMERIC GENE CARRIERS$336,375
R01 · FY2000 · HL
ANTIGAD MAB POLYMER CONJUGATES FOR DIABETES TREATMENT$227,176
R01 · FY2000 · DK